ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31377-50mg |
|
1201913-82-7 |
Tofogliflozin hydrate (CSG-452 hydrate)
|
0 | C22H28O7 | |
GC31377-10mg |
|
1201913-82-7 |
Tofogliflozin hydrate (CSG-452 hydrate)
|
0 | C22H28O7 | |
GC31377-5mg |
|
1201913-82-7 |
Tofogliflozin hydrate (CSG-452 hydrate)
|
0 | C22H28O7 | |
GC31377-2mg |
|
1201913-82-7 |
Tofogliflozin hydrate (CSG-452 hydrate)
|
0 | C22H28O7 | |
GC31377-10mM(1mLinDMSO) |
|
1201913-82-7 |
Tofogliflozin hydrate (CSG-452 hydrate)
|
0 | C22H28O7 | |
GC31376-100mg |
|
1355612-71-3 |
Aldose reductase-IN-1
|
0 | C17H10F3N5O3S | |
GC31376-50mg |
|
1355612-71-3 |
Aldose reductase-IN-1
|
0 | C17H10F3N5O3S | |
GC31376-10mg |
|
1355612-71-3 |
Aldose reductase-IN-1
|
0 | C17H10F3N5O3S | |
GC31376-5mg |
|
1355612-71-3 |
Aldose reductase-IN-1
|
0 | C17H10F3N5O3S | |
GC31376-10mM(1mLinDMSO) |
|
1355612-71-3 |
Aldose reductase-IN-1
|
0 | C17H10F3N5O3S | |
GC31375-100mg |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31375-50mg |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31375-25mg |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31375-10mg |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31375-5mg |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31375-10mM(1mLinDMSO) |
|
1808094-07-6 |
PF-06471553
|
0 | C23H25N5O4S | |
GC31374-5g |
|
282526-98-1 |
Cetilistat (ATL-962)
|
0 | C25H39NO3 | |
GC31374-1g |
|
282526-98-1 |
Cetilistat (ATL-962)
|
0 | C25H39NO3 | |
GC31374-500mg |
|
282526-98-1 |
Cetilistat (ATL-962)
|
0 | C25H39NO3 | |
GC31374-200mg |
|
282526-98-1 |
Cetilistat (ATL-962)
|
0 | C25H39NO3 | |